Woolsey Pharmaceuticals has a total of 59 patents globally, out of which 4 have been granted. Of these 59 patents, more than 98% patents are active. The USA is where Woolsey Pharmaceuticals has filed the maximum number of patents, followed by Europe (EPO) and Canada. Parallelly, the United States seems to be the main focused R&D center of Woolsey Pharmaceuticals and is also the origin country of the firm.
Woolsey Pharmaceuticals was founded in the year 2019 by David M. Geliebter and Sven M. Jacobson. The company is a pharmaceutical firm that specializes in reinventing ways to treat some of the world’s most challenging diseases.
Do read about some of the most popular patents of Woolsey Pharmaceuticals which have been covered by us in this article and also you can find Woolsey Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Woolsey Pharmaceuticals patent portfolio.
How many patents does Woolsey Pharmaceuticals have?
Woolsey Pharmaceuticals has a total of 59 patents globally. These patents belong to 20 unique patent families. Out of 59 patents, 58 patents are active.
How Many Patents did Woolsey Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Woolsey Pharmaceuticals Applications Filed | Woolsey Pharmaceuticals Patents Granted |
| 2022 | 9 | – |
| 2021 | 39 | – |
| 2020 | – | – |
| 2019 | – | – |
How many Woolsey Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Woolsey Pharmaceuticals File in Different Countries?
Where are Research Centres of Woolsey Pharmaceuticals Patents Located?
The R&D Centre of patents filed by Woolsey Pharmaceuticals is in the US.
Most Cited Woolsey Pharmaceuticals Patent
US11642352B2 is the most popular patent in the Woolsey Pharmaceuticals portfolio. It has received 2 citations so far.
List of Woolsey Pharmaceuticals Patents
| Woolsey Pharmaceuticals Patents | Title |
| US11779588B2 | Method Of Treating Amyotrophic Lateral Sclerosis |
| US11771704B1 | Methods Of Using Rho Kinase Inhibitors To Treat Alzheimer’S Disease |
| US11666583B2 | Methods Of Treating Cortical Dementia Associated Wandering |
| US11642352B2 | Methods Of Treating Wandering In Lewy Dody Dementia |
| US20230321114A1 | Methods Of Treating Age Related Cognitive Decline |
| US20230310447A1 | Methods Of Treating Age Related Cognitive Decline |
| US20230285409A1 | Methods Of Using Rho Kinase Inhibitors To Treat Vascular Dementia |
| US20230263806A1 | Methods Of Treating Proteinopathies |
| US20230255980A1 | Taste Masking Oral Formulations Of Fasudil |
| US20230248739A1 | Methods Of Treating Cortical Dementia Associated Wandering |
| US20230226073A1 | Methods Of Treating Proteinopathy Associated Wandering |
| US20230201219A1 | Methods Of Treating Agitation And Other Dementia Associated Behavioral Symptoms |
| US20230190765A1 | Methods Of Using Rho Kinase Inhibitors To Treat Alzheimer’S Disease |
| US20230080958A1 | Methods Of Treating Pseudobulbar Affect And Other Emotional Disturbances |
| US20220125799A1 | Methods Of Treating 4 Repeat Tauopathies |
| US20220047607A1 | Methods Of Treating Neurodevelopmental Disorders |
| EP4232041A1 | Methods Of Treating 4 Repeat Tauopathies |
| EP4203961A1 | Methods Of Treating Age Related Cognitive Decline |
| EP4203960A1 | Methods Of Treating Age Related Cognitive Decline |
| EP4181925A1 | Methods Of Treating Proteinopathies |
| EP4171564A1 | Methods Of Treating Neurodevelopmental Disorders |
| EP4164652A1 | Methods Of Using Rho Kinase Inhibitors To Treat Vascular Dementia |
| EP4138842A1 | Methods Of Using Rho Kinase Inhibitors To Treat Alzheimer’S Disease |
| EP4125910A1 | Methods Of Using Rho Kinase Inhibitors To Treat Frontotemporal Dementia |
| EP4125879A1 | Methods Of Treating Proteinopathy Associated Wandering |
| EP4103187A1 | Methods Of Treating Pseudobulbar Affect And Other Emotional Disturbances |
| EP4087564A1 | Methods Of Treating Cortical Dementia Associated Wandering |
| WO2023158789A1 | Oral Formulations Of Fasudil With Ion Exchange Resin |
| WO2023158787A1 | Taste Masking Oral Formulations Of Fasudil |
| WO2023097151A1 | Methods Of Treating Agitation And Other Dementia Associated Behavioral Symptoms |
| WO2023086468A1 | Method Of Treating Amyotrophic Lateral Sclerosis And Dosing Regimen For Same |
| WO2023063959A1 | Method Of Treating Amyotrophic Lateral Sclerosis |
| WO2022245719A1 | Methods Of Treating Depression And Anxiety |
| WO2022245708A1 | Methods Of Treating Depression And Anxiety |
| CA3193561A1 | Methods Of Treating 4 Repeat Tauopathies |
| CA3188722A1 | Methods Of Treating Age Related Cognitive Decline |
| CA3188718A1 | Methods Of Treating Age Related Cognitive Decline |
| CA3184122A1 | Methods Of Treating Proteinopathies |
| CA3180436A1 | Methods Of Treating Neurodevelopmental Disorders |
| CA3180411A1 | Methods Of Using Rho Kinase Inhibitors To Treat Vascular Dementia |
| CA3175183A1 | Methods Of Using Rho Kinase Inhibitors To Treat Alzheimer’S Disease |
| CA3170073A1 | Methods Of Treating Proteinopathy Associated Wandering |
| CA3169944A1 | Methods Of Using Rho Kinase Inhibitors To Treat Frontotemporal Dementia |
| CA3165379A1 | Methods Of Treating Pseudobulbar Affect And Other Emotional Disturbances |
| CA3162382A1 | Methods Of Treating Cortical Dementia Associated Wandering |
| JP2023530120A | Methods Of Using Rho Kinase Inhibitors To Treat Vascular Dementia |
| JP2023523706A | Methods Of Using Rho Kinase Inhibitors To Treat Alzheimer’S Disease |
| JP2023518707A | Methods Of Treating Wandering Associated With Proteinopathy |
| JP2023509970A | Methods Of Treating Wandering Associated With Cortical Dementia |
| MX2023002396A | Methods To Treat Age Related Cognitive Impairment |
| MX2023004523A | Tauopathy Treatment Methods Of 4 Repeats |
| MX2023002165A | Methods To Treat Age Related Cognitive Impairment |
| MX2023000600A | Protein Disease Treatment Methods |
| MX2022012957A | Methods Of Use Of Rho Kinase Inhibitors To Treat Alzheimer’S Disease |
| MX2022011519A | Methods Of Using Rho Kinase Inhibitors To Treat Frontotemporal Dementia |
| MX2022011518A | Methods To Treat Wandering Associated With Proteinopathy |
| MX2022009479A | Methods Of Treating Pseudobulbar Affect And Other Emotional Disturbances. |
| MX2022008513A | Methods Of Treating Cortical Dementia Associated Wandering. |
| US20210401853A1 | Methods Of Treating Neurodevelopmental Disorders |
What are Woolsey Pharmaceuticals’ key innovation segments?
What Technologies are Covered by Woolsey Pharmaceuticals?
The chart below distributes patents filed by Woolsey Pharmaceuticals